ArticlePharmacoEconomics - open2024
Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models.
Article in PharmacoEconomics - open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- How much can we save by applying artificial intelligence in evidence synthesis? Results from a pragmatic review to quantify workload efficiencies and cost savings.Frontiers in pharmacology · 2025Pooled it
- Automating cost-effectiveness models with agentic artificial intelligence: Case study and implications for value assessment.Journal of managed care & specialty pharmacy · 2026Article
- Leveraging generative artificial intelligence for the development of non-interventional research study protocols: a proof-of-concept feasibility study.BMC medical research methodology · 2026Article
- Ontology-driven generation of parameters for health technology assessment models: a prompt engineering study.International journal of technology assessment in health care · 2026Article
- Health economics evaluation of artificial intelligence in the field of oncology: a scoping review.Health economics review · 2026Review
- EU Joint Clinical Assessment: A Framework for Optimising Use with Cost-Effectiveness Decision-Making.Journal of market access & health policy · 2025Article
- Integration of Generative AI with Human Expertise in HEOR: A Hybrid Intelligence Framework.Advances in therapy · 2025Review
- Using Generative Artificial Intelligence in Health Economics and Outcomes Research: A Primer on Techniques and Breakthroughs.PharmacoEconomics - open · 2025Article
- Using AI in the Economic Evaluation of AI-Based Health Technologies.PharmacoEconomics · 2025Article
- Ethical Challenges and Opportunities of AI in End-of-Life Palliative Care: Integrative Review.Interactive journal of medical research · 2025Review
- Potential Meets Practicality: AI's Current Impact on the Evidence Generation and Synthesis Pipeline in Health Economics.Clinical and translational science · 2025Article
- Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2025Review
- R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17.Journal of comparative effectiveness research · 2025Article
- Is your curriculum GenAI-proof? A method for GenAI impact assessment and a case study.MedEdPublish (2016) · 2025Article
- The transformative impact of large language models on medical writing and publishing: current applications, challenges and future directions.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2024Review
- Automated Mass Extraction of Over 680,000 PICOs from Clinical Study Abstracts Using Generative AI: A Proof-of-Concept Study.Pharmaceutical medicine · 2024Article
- RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16.Journal of comparative effectiveness research · 2024Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrent generation large language models (LLMs) such as Generative Pre-Trained Transformer 4 (GPT-4) have achieved human-level performance on many tasks including the generation of computer code based on textual input. This study aimed to assess whether GPT-4 could be used to automatically programme two published health economic analyses.
methodsThe two analyses were partitioned survival models evaluating interventions in non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC). We developed prompts which instructed GPT-4 to programme the NSCLC and RCC models in R, and which provided descriptions of each model's methods, assumptions and parameter values. The results of the generated scripts were compared to the published values from the original, human-programmed models. The models were replicated 15 times to capture variability in GPT-4's output.
resultsGPT-4 fully replicated the NSCLC model with high accuracy: 100% (15/15) of the artificial intelligence (AI)-generated NSCLC models were error-free or contained a single minor error, and 93% (14/15) were completely error-free. GPT-4 closely replicated the RCC model, although human intervention was required to simplify an element of the model design (one of the model's fifteen input calculations) because it used too many sequential steps to be implemented in a single prompt. With this simplification, 87% (13/15) of the AI-generated RCC models were error-free or contained a single minor error, and 60% (9/15) were completely error-free. Error-free model scripts replicated the published incremental cost-effectiveness ratios to within 1%.
conclusionThis study provides a promising indication that GPT-4 can have practical applications in the automation of health economic model construction. Potential benefits include accelerated model development timelines and reduced costs of development. Further research is necessary to explore the generalisability of LLM-based automation across a larger sample of models.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.